Literature DB >> 8022866

Cyclothialidine and its congeners: a new class of DNA gyrase inhibitors.

E Goetschi1, P Angehrn, H Gmuender, P Hebeisen, H Link, R Masciadri, J Nielsen.   

Abstract

Cyclothialidine is a new, potent DNA gyrase inhibitor isolated from Streptomyces filipinensis. However, it exhibits hardly any growth-inhibitory activity against intact bacterial cells. To explore its potential with regard to the development of a new type of antibacterial, a flexible synthetic route was worked out (i) to investigate the structural requirements for DNA gyrase inhibition and (ii) to search for congeners exerting antibacterial activity. The structure of cyclothialidine was confirmed by total synthesis. Marked DNA gyrase inhibitory activity was found for a number of analogs, a common feature of them being the bicyclic 12-membered lactone bearing one phenolic hydroxy group. Congeners of cyclothialidine were found to exhibit a moderate, but broad-spectrum, in vitro activity against Gram-positive bacteria. Therefore, the DNA gyrase inhibitory principle contained in cyclothialidine can be considered as the basis for a new class of antibacterial agents.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8022866     DOI: 10.1016/0163-7258(93)90017-8

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  10 in total

1.  Mode of action of GR122222X, a novel inhibitor of bacterial DNA gyrase.

Authors:  M Oram; B Dosanjh; N A Gormley; C V Smith; L M Fisher; A Maxwell; K Duncan
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

2.  GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin.

Authors:  M Stieger; P Angehrn; B Wohlgensinger; H Gmünder
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

3.  Gene expression changes triggered by exposure of Haemophilus influenzae to novobiocin or ciprofloxacin: combined transcription and translation analysis.

Authors:  H Gmuender; K Kuratli; C P Gray; W Keck; S Evers
Journal:  Genome Res       Date:  2001-01       Impact factor: 9.043

4.  Thermodynamic computational approach to capture molecular recognition in the binding of different inhibitors to the DNA gyrase B subunit from Escherichia coli.

Authors:  Liane Saíz-Urra; Miguel Ángel Cabrera Pérez; Matheus Froeyen
Journal:  J Mol Model       Date:  2013-04-30       Impact factor: 1.810

5.  Molecular basis for the differential quinolone susceptibility of mycobacterial DNA gyrase.

Authors:  Rupesh Kumar; Bhavani Shankar Madhumathi; Valakunja Nagaraja
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

6.  Mycorrhiza-Tree-Herbivore Interactions: Alterations in Poplar Metabolome and Volatilome.

Authors:  Prasath Balaji Sivaprakasam Padmanaban; Maaria Rosenkranz; Peiyuan Zhu; Moritz Kaling; Anna Schmidt; Philippe Schmitt-Kopplin; Andrea Polle; Jörg-Peter Schnitzler
Journal:  Metabolites       Date:  2022-01-19

7.  Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor.

Authors:  N Nakada; H Gmünder; T Hirata; M Arisawa
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

8.  Gene network analysis of Aeromonas hydrophila for novel drug target discovery.

Authors:  Vijai Singh; Dharmendra Kumar Chaudhary; Indra Mani
Journal:  Syst Synth Biol       Date:  2012-05-22

9.  The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography.

Authors:  R J Lewis; O M Singh; C V Smith; T Skarzynski; A Maxwell; A J Wonacott; D B Wigley
Journal:  EMBO J       Date:  1996-03-15       Impact factor: 11.598

Review 10.  Exploiting bacterial DNA gyrase as a drug target: current state and perspectives.

Authors:  Frédéric Collin; Shantanu Karkare; Anthony Maxwell
Journal:  Appl Microbiol Biotechnol       Date:  2011-09-09       Impact factor: 4.813

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.